Kifa Therapeutics
PrivateLast Round
Seed
Mar 18, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kifa Therapeutics is a precision neuroscience company developing first-in-class, mutant-selective small-molecule therapies for genetically defined Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kifa Therapeutics Comparables
Compare Kifa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuron23 | 81% | |
| Brenig Therapeutics | 81% | |
| Denali Therapeutics | 74% |
Kifa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2026 |
Kifa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tennessee Technology Development Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$8M round with Tennessee Technology Development Corporation
Kifa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kifa Therapeutics's valuation, stock price, and market status.
Is Kifa Therapeutics a public or private company?
Kifa Therapeutics is a private company.
What is the current stock price of Kifa Therapeutics?
Kifa Therapeutics is a private company with no public stock price. Caplight tracks Kifa Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Kifa Therapeutics worth (valuation)?
Valuation information for Kifa Therapeutics is not publicly available.
Can I buy Kifa Therapeutics stock?
Kifa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kifa Therapeutics's last funding round?
Kifa Therapeutics's most recent funding round was Seed on March 18, 2026.
Who are the main investors in Kifa Therapeutics?
Key investors in Kifa Therapeutics include Tennessee Technology Development Corporation.
Will Kifa Therapeutics IPO soon?
No public IPO plans have been announced for Kifa Therapeutics.
How can I track Kifa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kifa Therapeutics's secondary market activity and sign up for updates.